5 Key Takeaways
-
1
Jeffery Daigrepont urged ophthalmology practices to distinguish useful AI solutions from hype as AI becomes embedded in everyday technologies.
-
2
Daigrepont cautioned that practices may commit to tools they do not need if they purchase AI before determining whether it will become a feature of existing systems.
-
3
He noted that technology markets can contract quickly, citing the decline from more than 600 electronic health record vendors to a handful.
-
4
Before contracting for AI, practices should understand who owns the intellectual property, how data are used, what happens if the product fails, and their termination rights.
-
5
Daigrepont encouraged practices to explore AI adoption with curiosity and skepticism and said the Academy offers no-cost vendor contract reviews.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







